Multicenter Investigation of Xanthine Oxidase Inhibitor Efficacy for CKD patients with Hyperuricemia
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 08 Sep 2017
At a glance
- Drugs Febuxostat (Primary) ; Topiroxostat (Primary)
- Indications Hyperuricaemia
- Focus Therapeutic Use
- Acronyms MIE-CKD
- 07 Sep 2017 Status changed from recruiting to active, no longer recruiting.
- 21 Jan 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan record.
- 13 Jan 2015 New trial record